Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Julphar
Harvard Business School
Chinese Patent Office
Colorcon
Cerilliant
Teva
Johnson and Johnson
Medtronic
Deloitte
UBS

Generated: January 22, 2018

DrugPatentWatch Database Preview

Details for Patent: 7,727,548

« Back to Dashboard

Summary for Patent: 7,727,548
Title:Rapidly disintegrable tablet containing polyvinyl alcohol
Abstract:The present invention provides a quickly disintegrating tablet which has quick disintegrability and solubility in an oral cavity, and does not have uncomfortable tastes such as bitterness, has a small variation of a tablet physical property even in storage under a humidifying condition, and has substantially no change in a medicine content in the tablet and tablet appearance and which is superior in stability; and a manufacturing method of the tablet. That is, it provides: a quickly disintegrating tablet which is prepared by blending a medicine with a saccharide and polyvinyl alcohol, which has small variations of tablet weight, tablet hardness, tablet diameter and tablet thickness, and which is superior in medicine stability in the tablet; and a manufacturing method of the tablet.
Inventor(s): Morita; Yutaka (Saitama, JP), Yasui; Masanobu (Saitama, JP), Ohwaki; Takayuki (Saitama, JP), Tsushima; Yuki (Saitama, JP)
Assignee: Eisai R&D Management Co., Ltd. (Tokyo, JP)
Application Number:10/203,687
Patent Claim Types:
see list of patent claims
Compound; Dosage form; Use;

Drugs Protected by US Patent 7,727,548

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 7,727,548

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan2000-56176Mar 01, 2000
PCT Information
PCT FiledMarch 01, 2001PCT Application Number:PCT/JP01/01575
PCT Publication Date:September 07, 2001PCT Publication Number: WO01/64190

International Patents Family Members for US Patent 7,727,548

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Portugal 1260215 ➤ Subscribe
Japan 4107842 ➤ Subscribe
Spain 2327898 ➤ Subscribe
European Patent Office 1260215 ➤ Subscribe
Denmark 1260215 ➤ Subscribe
Germany 60139379 ➤ Subscribe
Austria 437632 ➤ Subscribe
World Intellectual Property Organization (WIPO) 0164190 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Julphar
Covington
Baxter
Novartis
Deloitte
Healthtrust
Cipla
Farmers Insurance
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot